Literature DB >> 32037861

Phase I randomized single-blinded controlled study investigating the potential benefit of aerobic exercise in degenerative cerebellar disease.

Scott Barbuto1, Dario Martelli2, Isarime Babajide Omofuma2, Nancy Lee1, Sheng-Han Kuo3, Sunil Agrawal2, Seonjoo Lee4, Michael O'Dell5, Joel Stein5,6,7.   

Abstract

OBJECTIVES: To investigate whether people with cerebellar degeneration can perform rigorous aerobic exercise and to assess the clinical impact of training.
DESIGN: Randomized single-blinded controlled, feasibility study comparing aerobic training to no training.
SETTING: Home intervention, assessments conducted at an academic medical center.
SUBJECTS: Twenty individuals with cerebellar degeneration caused by a range of genetic disorders. INTERVENTION: Aerobic training consisted of four weeks of stationary bicycle training, five times per week for 30-minute sessions. Intensity ranged from 65% to 80% of the participant's maximal heart rate determined during cardiopulmonary exercise testing. MAIN MEASURES: Primary outcome measure was change in the Scale for the Assessment and Rating of Ataxia scores. Recruitment rate, adherence, drop-out, and adverse events were also determined. The treatment was considered technically feasible if participants achieved target training frequency, duration, and intensity.
RESULTS: The 20 participants mean age was 50 years (standard deviation 15.65 years) and average Scale for the Assessment and Rating of Ataxia score was 9.6 (standard deviation 3.13). Ten participants were randomized to aerobic training and 10 to no training. Seven participants in the aerobic group attained target training duration, frequency, and intensity. There was a mean reduction in ataxia severity of 2.1 points (standard deviation 1.26) with four weeks of aerobic training, whereas ataxia severity increased by 0.3 (standard deviation 0.62) in the control group over the same period. Walking speed, balance measures, and fitness also improved in individuals who performed aerobic exercise.
CONCLUSIONS: Rigorous aerobic training is feasible in people with cerebellar degeneration. Improvements in ataxia, balance, and gait are promising.

Entities:  

Keywords:  Ataxia; aerobic exercise; rehabilitation; spinocerebellar degeneration; treatment outcome

Mesh:

Year:  2020        PMID: 32037861      PMCID: PMC7311185          DOI: 10.1177/0269215520905073

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  23 in total

1.  Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases.

Authors:  Ichiro Miyai; Mizuki Ito; Noriaki Hattori; Masahito Mihara; Megumi Hatakenaka; Hajime Yagura; Gen Sobue; Masatoyo Nishizawa
Journal:  Neurorehabil Neural Repair       Date:  2011-12-02       Impact factor: 3.919

2.  Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training.

Authors:  Ann M Swank; John Horton; Jerome L Fleg; Gregg C Fonarow; Steven Keteyian; Lee Goldberg; Gene Wolfel; Eileen M Handberg; Dan Bensimhon; Marie-Christine Illiou; Marianne Vest; Greg Ewald; Gordon Blackburn; Eric Leifer; Lawton Cooper; William E Kraus
Journal:  Circ Heart Fail       Date:  2012-07-06       Impact factor: 8.790

3.  The condition for dynamic stability.

Authors:  A L Hof; M G J Gazendam; W E Sinke
Journal:  J Biomech       Date:  2005-01       Impact factor: 2.712

4.  Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor.

Authors:  Ruo-Yah Lai; Darya Tomishon; Karla P Figueroa; Stefan M Pulst; Susan Perlman; George Wilmot; Christopher M Gomez; Jeremy D Schmahmann; Henry Paulson; Vikram G Shakkottai; Sarah H Ying; Theresa Zesiewicz; Khalaf Bushara; Michael Geschwind; Guangbin Xia; S H Subramony; Tetsuo Ashizawa; Sheng-Han Kuo
Journal:  Cerebellum       Date:  2019-06       Impact factor: 3.847

5.  A home balance exercise program improves walking in people with cerebellar ataxia.

Authors:  Jennifer L Keller; Amy J Bastian
Journal:  Neurorehabil Neural Repair       Date:  2014-02-13       Impact factor: 3.919

6.  Gait parameters and stride-to-stride variability during familiarization to walking on a split-belt treadmill.

Authors:  Joseph A Zeni; Jill S Higginson
Journal:  Clin Biomech (Bristol, Avon)       Date:  2009-12-09       Impact factor: 2.063

7.  Usefulness of the Scale for Assessment and Rating of Ataxia (SARA).

Authors:  Ichiro Yabe; Masaaki Matsushima; Hiroyuki Soma; Rehana Basri; Hidenao Sasaki
Journal:  J Neurol Sci       Date:  2007-10-22       Impact factor: 3.181

8.  Intensive coordinative training improves motor performance in degenerative cerebellar disease.

Authors:  W Ilg; M Synofzik; D Brötz; S Burkard; M A Giese; L Schöls
Journal:  Neurology       Date:  2009-10-28       Impact factor: 9.910

9.  Video game-based coordinative training improves ataxia in children with degenerative ataxia.

Authors:  Winfried Ilg; Cornelia Schatton; Julia Schicks; Martin A Giese; Ludger Schöls; Matthis Synofzik
Journal:  Neurology       Date:  2012-10-31       Impact factor: 9.910

Review 10.  Effectiveness and safety of treatments for degenerative ataxias: a systematic review.

Authors:  M Mar Trujillo-Martín; Pedro Serrano-Aguilar; Fernando Monton-Alvarez; Romen Carrillo-Fumero
Journal:  Mov Disord       Date:  2009-06-15       Impact factor: 10.338

View more
  2 in total

1.  Home Aerobic Training for Cerebellar Degenerative Diseases: a Randomized Controlled Trial.

Authors:  Scott Barbuto; Sheng-Han Kuo; Lauren Winterbottom; Seonjoo Lee; Yaakov Stern; Michael O'Dell; Joel Stein
Journal:  Cerebellum       Date:  2022-03-18       Impact factor: 3.648

2.  Activation of TrkB-Akt signaling rescues deficits in a mouse model of SCA6.

Authors:  Anna A Cook; Sriram Jayabal; Jacky Sheng; Eviatar Fields; Tsz Chui Sophia Leung; Sabrina Quilez; Eileen McNicholas; Lois Lau; Shixia Huang; Alanna J Watt
Journal:  Sci Adv       Date:  2022-09-16       Impact factor: 14.957

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.